How much funding has Immatics N.V. raised?

Immatics N.V. has raised $346.7M in total funding, most recently a Corporate Round.

Who are Immatics N.V.'s investors?

Immatics N.V.'s investors include Wellington Management, Jefferies, CA Healthcare Acquisition Corp, dievini Hopp Biotech holding, Cantor, SVB Leerink.

When was Immatics N.V. founded?

Immatics N.V. was founded in 2000.

Where is Immatics N.V. headquartered?

Immatics N.V. is headquartered in Tuebingen, Germany.

What industry is Immatics N.V. in?

Immatics N.V. operates in Biotech, Healthcare.

How many employees does Immatics N.V. have?

Immatics N.V. has 201-500 employees.

Immatics N.V.

IPO

Immatics

Public · Tuebingen, Germany · Founded 2000 · $346.7M raised

Biotech

Healthcare

Headquarters: Tuebingen
Employees: 201–500
Founded: 2000
Business Model: B2B
Website: immatics.com

Total Funding: $346.7M
Last Round: $125.0M Corporate RoundDec 2025
Rounds: 8
Type: Public

About

Immatics N.V. is a clinical-stage biopharmaceutical company founded in 2000 as a spin-out from the University of Tübingen, Germany. The company is the global leader in PRAME-targeted cancer immunotherapy, developing both T cell receptor-based adoptive cell therapies (ACTengine®) and TCR bispecifics across more than 50 cancer indications.

Summary

Immatics N.V. is a Biotech company based in Tuebingen, Germany, founded in 2000. It has raised $346.7M in total across 8 rounds, most recently a $125.0M Corporate Round round in Dec 2025. Investors include Wellington Management, Jefferies and CA Healthcare Acquisition Corp.

LinkedIn X (Twitter)